Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Actual. osteol ; 13(1): 28-36, Ene - Abr. 2017. tab
Article in Spanish | LILACS | ID: biblio-1118788

ABSTRACT

El pico de masa ósea (PMO) se alcanza entre los 20 y 35 años, pero la aposición ósea continúa hasta alcanzar el pico de fortaleza ósea (PFO). Se crea así una ventana entre ambos picos que podría ser evaluada mediante marcadores bioquímicos de recambio óseo, ya que durante dicho período la densidad mineral permanece constante. El objetivo fue determinar el final de la aposición ósea mediante marcadores bioquímicos óseos. Se evaluaron por décadas entre 20 y 49 años de edad 139 sujetos sanos de ambos sexos (69 hombres y 70 mujeres), determinando fosfatasa alcalina ósea (FAO), osteocalcina (OC), propéptido amino terminal del colágeno tipo 1 (P1NP) y telopéptido C-terminal del colágeno tipo 1 (CTX). Los marcadores correlacionan negativamente con la edad (OC: r= -0,3; p<0,01; P1NP: r= -0,4; p< 0,01 y CTX: r= -0,4; p<0,01), exceptuando FAO. En hombres de 20-29 años, P1NP y el CTX fueron significativamente mayores vs. 30-39 años (p<0,05 y p<0,001, respectivamente), y entre 30-39 años vs. de 40-49 años en P1NP y CTX (p<0,05; p<0,001, respectivamente). En mujeres de 20-29 años, P1NP y CTX fueron significativamente mayores vs. 30-39 años (p<0,0001 y p<0,01, respectivamente). Conclusión: los marcadores de remodelado óseo más sensibles y específicos permitirían determinar bioquímicamente el fin de la aposición ósea que se produce entre el PMO y el PFO. Si bien es necesario ampliar el número de sujetos evaluados, los datos que surgen de la presente investigación sentarían las bases para futuros estudios epidemiológicos referidos al fin de la aposición ósea. (AU)


Peak bone mass is achieved between 20-35 years; however bone apposition continues to reach an optimal skeleton strength. The window between peak bone mass and peak bone apposition may be evaluated by biochemical bone turnover markers. The objective of this study was to determine the end of bone apposition through biochemical bone markers in both sexes. A total of 139 subjects (69 men and 70 women) were divided by decades between 20 and 49 years of age. Bone alkaline phosphatase (BAL), osteocalcin (OC), type I collagen propeptide (P1NP) and type I collagen C-terminal telopeptide (CTX) were evaluated. Except BAL, the other bone markers negatively correlated with the age [OC (r= -0.3; p<0.01); P1NP (r= -0.4; p<0.01) and CTX (r= -0.4; p<0.01)]. Regarding men aged 20 to 29 years, P1NP and CTX were significantly higher vs. 30-39 years (p<0.05 y p<0.001, respectively) and. vs. 40-49 years (p<0.05; p<0.001, respectively). In women, the results were similar. Regarding 20-29 years, P1NP and CTX were higher vs. 30-39 years (p<0.001 y p<0.01, respectively). Bone remodeling rate decreases after the third decade, suggesting the end of the apposition period of peak bone mass. Conclusion: The most specific and sensitive bone markers would biochemically determine the end of bone apposition that extends between the peak of bone mass and the peak of bone strength. Although it is necessary to increase the number of subjects evaluated, the data that emerge from the present study would establish the bases for future epidemiological studies referring to the end of bone apposition. (AU)


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Young Adult , Bone Resorption/physiopathology , Biomarkers , Osteoblasts/physiology , Osteoclasts/physiology , Osteogenesis/physiology , Bone and Bones/metabolism , Bone Density/physiology , Osteocalcin/blood , Calcium/blood , Age Factors , Bone Remodeling/physiology , Creatinine/blood , Collagen Type I/biosynthesis , Collagen Type I/blood , Densitometry , Alkaline Phosphatase/blood , Osteoporotic Fractures/prevention & control
2.
Braz. j. med. biol. res ; 47(10): 850-857, 10/2014. tab, graf
Article in English | LILACS | ID: lil-722172

ABSTRACT

We previously described a selective bile duct ligation model to elucidate the process of hepatic fibrogenesis in children with biliary atresia or intrahepatic biliary stenosis. Using this model, we identified changes in the expression of alpha smooth muscle actin (α-SMA) both in the obstructed parenchyma and in the hepatic parenchyma adjacent to the obstruction. However, the expression profiles of desmin and TGF-β1, molecules known to be involved in hepatic fibrogenesis, were unchanged when analyzed by semiquantitative polymerase chain reaction (RT-PCR). Thus, the molecular mechanisms involved in the modulation of liver fibrosis in this experimental model are not fully understood. This study aimed to evaluate the molecular changes in an experimental model of selective bile duct ligation and to compare the gene expression changes observed in RT-PCR and in real-time quantitative PCR (qRT‐PCR). Twenty-eight Wistar rats of both sexes and weaning age (21-23 days old) were used. The rats were separated into groups that were assessed 7 or 60 days after selective biliary duct ligation. The expression of desmin, α-SMA and TGF-β1 was examined in tissue from hepatic parenchyma with biliary obstruction (BO) and in hepatic parenchyma without biliary obstruction (WBO), using RT-PCR and qRT‐PCR. The results obtained in this study using these two methods were significantly different. The BO parenchyma had a more severe fibrogenic reaction, with increased α-SMA and TGF-β1 expression after 7 days. The WBO parenchyma presented a later, fibrotic response, with increased desmin expression 7 days after surgery and increased α-SMA 60 days after surgery. The qRT‐PCR technique was more sensitive to expression changes than the semiquantitative method.


Subject(s)
Animals , Female , Male , Actins/metabolism , Cholestasis/complications , Desmin/metabolism , Liver Cirrhosis/etiology , Liver/metabolism , Real-Time Polymerase Chain Reaction/methods , Transforming Growth Factor beta1/metabolism , Analysis of Variance , Actins/genetics , Biliary Atresia , Bile Ducts/surgery , Collagen Type I/biosynthesis , Disease Models, Animal , Desmin/genetics , Gene Expression , Ligation , Liver Cirrhosis/metabolism , Liver/surgery , Rats, Wistar , Transforming Growth Factor beta1/genetics
3.
Int. braz. j. urol ; 40(2): 257-265, Mar-Apr/2014. graf
Article in English | LILACS | ID: lil-711695

ABSTRACT

PurposeTo evaluate the synthesis of type I (mature) and type III (immature) collagen in bladder suture of rats treated with a combination of tacrolimus and mycophenolate mofetil for 15 days.Materials and MethodsThirty rats were divided into 3 groups: the sham, control and experimental groups. All the animals underwent laparotomy, cystotomy and bladder suture in two planes with surgical PDS 5-0 thread. The sham group did not receive treatment. The control group received saline solution, and the experimental group received 0.1mg/kg/day of tacrolimus with 20mg/kg/day of mycophenolate mofetil, for 15 days. From then on, the tacrolimus was dosed. The surgical specimens of the bladder suture area were processed so that the total type I and type III collagen could be measured by the picrosirius red technique.ResultsThere was a predominance of type I collagen production in the sham and control groups compared to the experimental group, in which type III collagen was predominant. The production of total collagen did not change.ConclusionThe association of tacrolimus and mycophenolate mofetil in animals qualitatively changes the production of collagen after 15 days with a predominance of type III collagen.


Subject(s)
Animals , Collagen Type I/biosynthesis , Collagen Type III/biosynthesis , Immunosuppressive Agents/therapeutic use , Mycophenolic Acid/analogs & derivatives , Sutures , Tacrolimus/therapeutic use , Urinary Bladder/surgery , Collagen Type I/drug effects , Collagen Type III/drug effects , Mycophenolic Acid/therapeutic use , Rats, Wistar , Reproducibility of Results , Suture Techniques , Treatment Outcome , Wound Healing/drug effects
4.
Braz. dent. j ; 21(6): 491-498, 2010. ilus, tab
Article in English | LILACS | ID: lil-572294

ABSTRACT

The aim of this study was to investigate the effects of low-level laser therapy (LLLT) by using gallium aluminum arsenide (GaAlAs) diode laser on human osteoblastic cells grown on titanium (Ti). Osteoblastic cells were obtained by enzymatic digestion of human alveolar bone and cultured on Ti discs for up to 17 days. Cells were exposed to LLLT at 3 J/cm2 (wavelength of 780 nm) at days 3 and 7 and non-irradiated cultures were used as control. LLLT treatment did not influence culture growth, ALP activity, and mineralized matrix formation. Analysis of cultures by epifluorescence microscopy revealed an area without cells in LLLT treated cultures, which was repopulated latter with proliferative and less differentiated cells. Gene expression of ALP, OC, BSP, and BMP-7 was higher in LLLT treated cultures, while Runx2, OPN, and OPG were lower. These results indicate that LLLT modulates cell responses in a complex way stimulating osteoblastic differentiation, which suggests possible benefits on implant osseointegration despite a transient deleterious effect immediately after laser irradiation.


Este estudo teve como objetivo investigar o efeito do laser diodo de gálio-alumínio-arsênio (GaAlAs) em células osteoblásticas humanas cultivadas sobre discos de Ti. Para tanto, células osteoblásticas foram obtidas por digestão enzimática de osso alveolar humano e cultivadas sobre discos de Ti por 17 dias. As células foram submetidas à irradiação no 3º e 7º dias na dose de 3 J/cm2 e comprimento de onda de 780 nm e células não irradiadas foram usadas como controle. A irradiação não alterou a proliferação celular, atividade de ALP e formação de matriz mineralizada. Microscopia por epifluorescência indicou que após 24 h da aplicação do laser, as culturas irradiadas apresentaram áreas sem células, que mais tarde foram repovoadas por células em fase de proliferação e menos diferenciadas. O laser aumentou a expressão gênica relativa da ALP, OC, BSP e BMP-7 e reduziu a de RUNX2, OPN e OPG. Os resultados indicam que a terapia com laser modula de forma complexa as respostas celulares, estimulando a diferenciação osteoblástica. Assim, é possível sugerir possíveis benefícios do laser na osseointegração de implantes de Ti apesar do efeito deletério às células imediatamente após a irradiação.


Subject(s)
Humans , Bone Matrix/growth & development , Gene Expression/radiation effects , Low-Level Light Therapy , Osseointegration/radiation effects , Osteoblasts/radiation effects , Analysis of Variance , Alkaline Phosphatase/biosynthesis , Alkaline Phosphatase/genetics , /biosynthesis , /genetics , Cells, Cultured/radiation effects , Collagen Type I/biosynthesis , Collagen Type I/genetics , Core Binding Factor Alpha 1 Subunit/biosynthesis , Core Binding Factor Alpha 1 Subunit/genetics , Integrin-Binding Sialoprotein/biosynthesis , Integrin-Binding Sialoprotein/genetics , Intercellular Adhesion Molecule-1/biosynthesis , Intercellular Adhesion Molecule-1/genetics , Lasers, Semiconductor/therapeutic use , Osteoblasts/metabolism , Osteocalcin/biosynthesis , Osteocalcin/genetics , Osteopontin/biosynthesis , Osteopontin/genetics , Osteoprotegerin/biosynthesis , Osteoprotegerin/genetics , RANK Ligand/biosynthesis , RANK Ligand/genetics , Statistics, Nonparametric , Titanium
5.
Biocell ; 33(1): 39-47, Apr. 2009. ilus
Article in English | LILACS | ID: lil-595028

ABSTRACT

Progenitor cells play an important biological role in tooth and bone formation, and previous analyses during bone and dentine induction have indicated that they may be a good alternative for tissue engineering. Thus, to clarify the influence of the microenvironment on protein and gene expression, MDPC-23 cells (mouse dental papilla cell line) and KUSA/A1 cells (bone marrow stromal cell line) were used, both in vitro cell culture and in intra-abdominal diffusion chambers implanted in 4-week-old male immunodefficient mice (SCID mice). Our results indicate that KUSA/A1 cells differentiated into osteoblast-like cells and induced bone tissue inside the chamber, whereas, MDPC-23 showed odontoblast-like characteristics but with a low ability to induce dentin formation. This study shows that MDPC-23 cells are especial cel ls, which possess morphological and functional characteristics of odontoblast-like cells expressing dentin sialophosphoprotein in vivo. In contrast, dentin sialophosphoprotein gene and protein expression was not detected in both cell lines in vitro. The intra-abdominal diffusion chamber appears as an interesting experimental model for studying phenotypic expression of dental pulp cells in vivo.


Subject(s)
Male , Animals , Mice , Collagen Type I/biosynthesis , Collagen Type I/genetics , Odontoblasts/cytology , Odontoblasts/metabolism , Bone Regeneration/physiology , Bone Regeneration/genetics , Sialoglycoproteins/biosynthesis , Sialoglycoproteins/genetics , Bone and Bones/cytology , Bone and Bones/metabolism , Mice, SCID , Osteocalcin/biosynthesis , Osteocalcin/genetics , Osteonectin/biosynthesis , Osteonectin/genetics , Osteopontin/biosynthesis , Osteopontin/genetics
6.
Article in English | IMSEAR | ID: sea-39184

ABSTRACT

A study of 109 female volunteers in good health and reproductive life, the mean age was 38.5 years, the volunteers had no intake of any kind of medicine before blood examination. The mean value of PINP is 44.57 ng/ml, standard deviation= 19.91, standard error= 1.9 with 95% confident interval = 40.79 to 48.35 ng/ml The PINP is a bone formation marker which is secreted by osteoblast, the advantage of the present study was helping the evaluation of bone status after bone forming agents therapy. In addition PINP showed the status of bone turnover when compared to bone resorption marker (CTx).


Subject(s)
Adult , Biomarkers , Bone Resorption/blood , Collagen Type I/biosynthesis , Female , Humans , Middle Aged , Osteoblasts/metabolism , Peptide Fragments , Reference Values
7.
Southeast Asian J Trop Med Public Health ; 2005 Jul; 36(4): 1066-9
Article in English | IMSEAR | ID: sea-31865

ABSTRACT

Retinoic acid has been known to play a key role in the regulation of bone cell differentiation and function. The effects of retinoic acid on human dental pulp cells, which contain several characteristics similar to those of bone cells, has yet to be elucidated extensively. The effects of retinoic acid on human dental pulp cells in terms of type I collagen and osteocalcin induction were investigated in vitro. Dental pulp cells obtained from the teeth of young patients (age between 18-22 years) were cultured and subsequently treated with various concentrations of retinoic acid (0, 10(-7), 10(-6), 10(-5) M) in serum-free DMEM. At different time intervals (8, 12 and 24 hours), the levels of type I collagen and osteocalcin secreted were determined using Type I Procollagen C-Peptide and Gla-type Osteocalcin EIA kits, respectively. Induction effects were evaluated using analysis of variance and the Duncan's multiple rank test. Retinoic acid at concentrations of 10(-5), 10(-6), 10(-7) M was able to induce type I collagen and osteocalcin production in human dental pulp cells within 12 hours of exposure. Dose-dependent induction was observed only after 24 hours. A two-fold increase in osteocalcin level was detected after exposed to 10(-5) M retinoic acid within 24 hours. Our data suggest that retinoic acid at concentrations of 10(-5), 10(-6), 10(-7) M has the ability to induce type I collagen and osteocalcin secretions in human dental pulp cells in vitro.


Subject(s)
Adolescent , Adult , Cells, Cultured , Collagen Type I/biosynthesis , Dental Pulp/cytology , Female , Humans , Male , Osteocalcin/biosynthesis , Thailand , Time Factors , Tretinoin/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL